文献速递慢性肾脏病水电解质与酸碱

继发性甲状旁腺功能亢进的外科管理

Surgical Management of Secondary Hyperparathyroidism.
PubMed 文献 · Kidney Int Rep · 2020-12-30

本文为叙事性综述,总结继发性甲状旁腺功能亢进(SHPT)外科转诊指征、术前规划、术中切除策略及术后管理。多数研究采用PTH>800 pg/ml伴高钙和/或高磷作为手术标准,SPECT/CT影像敏感性最高,术中PTH监测可预测长期治愈。

要点

  • PTH>800 pg/ml伴高钙和/或高磷可考虑转诊甲状旁腺外科。
  • SPECT/CT在SHPT术前定位中敏感性最高。
  • 术后需警惕严重低钙血症和骨饥饿综合征。

核心结论

  • 药物治疗失败的SHPT患者应转诊甲状旁腺外科,术中PTH监测有助于预测长期治愈。

研究设计与样本

  • 叙事性综述,总结SHPT外科转诊指征、术前规划、术中策略和术后管理。

主要发现

  • 多数评估甲状旁腺切除术的研究采用PTH>800 pg/ml伴高钙和/或高磷作为标准。
  • SPECT/CT在SHPT各种影像模式中似乎最敏感。
  • 术中PTH监测可有效预测SHPT长期治愈,但不能预测甲状旁腺功能减退。
  • 异位和额外甲状旁腺常见,常与持续或复发疾病相关。
  • 术后患者有严重低钙血症和骨饥饿综合征风险,需密切监测和补充。

关键数值与推荐

  • 甲状旁腺切除术研究常用标准:PTH>800 pg/ml伴高钙和/或高磷,可伴骨痛和瘙痒。
  • SPECT/CT在SHPT影像评估中似乎敏感性最高。

临床怎么用

  • 对药物治疗失败且符合PTH>800 pg/ml伴高钙和/或高磷的SHPT患者考虑转诊外科。
  • 术前优先选择SPECT/CT定位,术中监测PTH预测长期治愈。
  • 术后密切监测血钙并补充,警惕骨饥饿综合征。

局限性

  • 缺乏通用指南,转诊时机难以确定。
  • 各种影像模式在SHPT中的效用报告差异很大。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Secondary hyperparathyroidism (SHPT) affects a majority of patients with chronic kidney disease (CKD) of stage 3 or worse. Despite the development of calcimimetics and their effectiveness in treating SHPT, many patients continue to fail medical management and should be referred to a parathyroid surgeon. In this narrative review, we summarize the indications for surgical referral, preoperative planning, intraoperative strategies to guide resection, and postoperative management. In the absence of universal guidelines, it can be difficult to determine when it is appropriate to make this referral. The majority of studies evaluating parathyroidectomy (PTX) for SHPT use the criteria of parathyroid hormone level (PTH) >800 pg/ml with hypercalcemia and/or hyperphosphatemia, which may be accompanied by symptoms such as bone pain and pruritis that can improve after surgery. Although the reported utility of the various imaging modalities (i.e., 99m-technetium-sestamibi scintigraphy with computed tomography [SPECT/CT], CT, or ultrasound) is highly variable in SHPT, SPECT/CT appears to be the most sensitive. Intraoperatively, PTH monitoring is effective in predicting long-term cure of SHPT but not in predicting hypoparathyroidism. Ectopic and supernumerary parathyroid glands are common in these patients and are often implicated in persistent or recurrent disease. Postoperatively, patients are at risk of severe hypocalcemia and hungry bone syndrome requiring close monitoring and replenishment.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Steinl GK, Kuo JH. Surgical Management of Secondary Hyperparathyroidism. Kidney Int Rep. 2020. PMID: 33615051. doi:10.1016/j.ekir.2020.11.023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。